Track CTTH and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$4.06M
Enterprise Value$4.07M
Revenue (TTM)-
Net Income (TTM)-$155.91K
Free Cash Flow (TTM)-$75.47K
Financial Health
Cash$15.36K
Net Debt$3.46K
Debt Ratio0.22
Debt to Equity0.34
Interest Coverage-7.33
Valuation (TTM)
Price to Sales-
Price to Earnings-26.07
EV to EBITDA-35.71
Price to Book73.68
Price to Free Cash Flow-53.85
Margins (TTM)
Gross Profit Margin-
EBITDA Margin-
Operating Income Margin-
Net Income Margin-
Free Cash Flow Margin-
Returns (5Y Avg)
Return on Invested Capital581.39%
Return on Assets-293.60%
Return on Equity-43.27%
Return on Total Capital581.39%
Return on Capital Employed-59.61%
Dividend Summary
Dividend Yield-
Annual Dividend-
Payout Ratio-
Ex Dividend Date-
5-Year Dividend CAGR-
CAGR (5Y)
Revenue0.00%
Diluted EPS0.19%
Total Debt615.98%
Capital Expenditures31.95%
Free Cash Flow4.86%
CAGR (3Y)
Revenue0.00%
Diluted EPS-0.05%
Total Debt1000.00%
Capital Expenditures58.74%
Free Cash Flow1000.00%
CAGR (1Y)
Revenue0.00%
Diluted EPS0.12%
Total Debt11.11%
Capital Expenditures200.00%
Free Cash Flow-100.00%
$0.06-$0.00|-3.79%
52W High$0.10
52W Low$0.03
50D SMA$0.08
200D SMA$0.07
Volume17.25K
CTT Pharmaceutical Holdings Inc
3853 Northdale Blvd, Tampa, FL, United States, 33624
IPO
-
Employees
1
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Insider Transactions
Quarterly buy vs. sell activity
No insider transactions data available for this period
Analyst Ratings
No coverage data
No analyst ratings data available